Especifique uma ação ou criptomoeda na barra de pesquisa para obter um resumo
Histórico de Dividendos AVDL
Análise de Dividendos AVDL
Max Ratio
–Crescimento de dividendos em 5 anos
–Crescimento contínuo
–Taxa de pagamento em média de 5 anos
–Avadel Pharmaceuticals PLC
AVDLAvadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is the LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of cataplexy or excessive daytime sleepiness in patients seven years of age and older with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin 2, Ireland. Address: 10 Earlsfort Terrace, Dublin, Ireland, D02 T380
Analytics
Preço Alvo de Wall Street
16.57 USDRácio P/E
–Rendimento de dividendos
–Relatório AVDL
Acompanhe as principais métricas de cada ação em um só lugar, sem complicações
Inscreva-se no premiumResultados | 2019 | Dinâmica |